1. Home
  2. MTSR vs SHC Comparison

MTSR vs SHC Comparison

Compare MTSR & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • SHC
  • Stock Information
  • Founded
  • MTSR 2022
  • SHC 2015
  • Country
  • MTSR United States
  • SHC United States
  • Employees
  • MTSR N/A
  • SHC N/A
  • Industry
  • MTSR
  • SHC Medical Specialities
  • Sector
  • MTSR
  • SHC Health Care
  • Exchange
  • MTSR NYSE
  • SHC Nasdaq
  • Market Cap
  • MTSR 3.0B
  • SHC 3.2B
  • IPO Year
  • MTSR 2025
  • SHC 2020
  • Fundamental
  • Price
  • MTSR $40.47
  • SHC $12.30
  • Analyst Decision
  • MTSR Strong Buy
  • SHC Strong Buy
  • Analyst Count
  • MTSR 6
  • SHC 5
  • Target Price
  • MTSR $55.25
  • SHC $16.00
  • AVG Volume (30 Days)
  • MTSR 803.5K
  • SHC 1.0M
  • Earning Date
  • MTSR 08-26-2025
  • SHC 08-08-2025
  • Dividend Yield
  • MTSR N/A
  • SHC N/A
  • EPS Growth
  • MTSR N/A
  • SHC N/A
  • EPS
  • MTSR N/A
  • SHC 0.09
  • Revenue
  • MTSR N/A
  • SHC $1,106,788,000.00
  • Revenue This Year
  • MTSR N/A
  • SHC $4.78
  • Revenue Next Year
  • MTSR N/A
  • SHC $5.90
  • P/E Ratio
  • MTSR N/A
  • SHC $140.58
  • Revenue Growth
  • MTSR N/A
  • SHC 2.78
  • 52 Week Low
  • MTSR $12.30
  • SHC $9.53
  • 52 Week High
  • MTSR $47.40
  • SHC $17.08
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • SHC 62.92
  • Support Level
  • MTSR N/A
  • SHC $10.98
  • Resistance Level
  • MTSR N/A
  • SHC $12.68
  • Average True Range (ATR)
  • MTSR 0.00
  • SHC 0.40
  • MACD
  • MTSR 0.00
  • SHC 0.11
  • Stochastic Oscillator
  • MTSR 0.00
  • SHC 78.39

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Share on Social Networks: